The ongoing conundrum of the best care for patients presenting with non-ST-segment elevation acute coronary syndrome

EuroIntervention 2022;18:531-533. DOI: 10.4244/EIJ-E-22-00029

Vijay Kunadian
Vijay Kunadian1,2, MBBS, MD, FRCP
1. Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; 2. Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundations Trust, Newcastle upon Tyne, UK
The world’s biggest killer is ischaemic heart disease, which was responsible for 16% of the world’s total deaths in 2019. Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is a syndrome that encompasses unstable angina and non-ST-segment elevation myocardial infarction (MI). Patients in this heterogeneous population (Figure 1) account for the majority of ACS presentations, but management strategies for this group have remained a subject of debate for decades. In this issue of EuroIntervention, Eggers et al1 show that coronary angiography of NSTE-ACS patients performed within 24-72 hours (vs ≤24 hours) is not associated with worse outcomes (all-cause mortality, major adverse ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Recanalisation of coronary chronic total occlusions

Latest news